Acadia Pharmaceuticals

Product Manager - Reproductive Medicine

West Drayton, England, United Kingdom

$120,000 – $160,000Compensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should possess a minimum of 2 years of experience in Pharmaceutical Marketing, with experience in Digital Marketing and brand management. A degree in Business, Marketing, or Life Sciences is required, along with in-depth knowledge of the pharmaceutical industry and adherence to the ABPI Code of Practice.

Responsibilities

The Product Manager - Reproductive Medicine will design and adapt international product strategies to local markets, develop and implement marketing plans for specific products, conduct competitor analysis and market data analysis, develop and execute omnichannel digital marketing plans, adapt and develop promotional material, present material to relevant teams, maintain relationships with Key Opinion Leaders (KOLs) and scientific societies, participate in sales-related tasks, attend scientific meetings, track marketing, revenue, and spend KPIs, monitor progress with tactical plans, collaborate effectively with internal stakeholders, and ensure compliance with the ABPI Code of Practice.

Skills

Pharmaceutical Marketing
Digital Marketing
Brand Management
Market Data Analysis
Competitor Analysis
Omnichannel Marketing
Promotional Material Development
Key Opinion Leader (KOL) Management
Sales Tasks
Marketing KPIs
Strategic Planning
Stakeholder Collaboration
ABPI Code of Practice

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Key Metrics

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI